Breaking News

BioScreen Completes FDA Inspection

July 8, 2014

Inspection covered quality system and lab facilities in Torrance, CA

BioScreen Testing Services, Inc. has successfully completed an FDA audit of their lab facility in Torrance, CA, with no 483 citations issued. The inspection covered BioScreen’s quality system as well as all lab facilities, and expanded chemistry and microbiology labs. 
 
"The results from the FDA audit are extremely positive and serve as a testament to the high Quality Standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president of BioScreen.
 
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news

Related Compliance:

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Heavy Metals in Drug Products

    Heavy Metals in Drug Products

    Nikki Schopp, Team Leader in charge of ICP-MS, ICP-OES and AA testing, SGS||January 29, 2015
    The potential presence of trace amounts of heavy metals in drug products is a real cause for concern with regulators.

  • Microbiological Testing & Contamination Control

    Microbiological Testing & Contamination Control

    Daniel L. Prince, Ph. D., Christopher J. Waskewich, M.S., Kristah J. Kohan, B.S. and Danina G. Rinaldi, B.S. , Gibraltar Laboratories, Inc.||March 7, 2014
    An opinion on the microbial limit test with reference to harmonization.